HOMA-IR: the insulin resistance marker your standard panel might miss
A standard annual panel can miss insulin resistance for years. HOMA-IR is a quick math step that catches it sooner.
TL;DR
- HOMA-IR estimates how resistant your cells are to insulin from two routine fasting labs.
- It often rises before fasting glucose or A1c look abnormal.
- Most references treat scores under 1.5 as healthy and scores above 2.5 as suggestive of insulin resistance.
What it is
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance (in plain English: a quick formula that uses two fasting blood tests to estimate how well your cells respond to insulin). It was first described by Matthews and colleagues in 1985 and has been used in thousands of published studies since. The two ingredients are fasting glucose and fasting insulin — labs that are inexpensive and widely available.
How it works
Think of insulin as a key. Glucose is a delivery van waiting at the cell door. If the locks work well, the key turns easily and the glucose goes inside. If the locks are sticky — insulin resistance — the body has to make more keys to get the same delivery through. HOMA-IR captures that situation by multiplying fasting insulin by fasting glucose and dividing by 405 (Matthews et al., Diabetologia, 1985). Higher numbers mean more keys per delivery — more insulin resistance.
Who asks about it
People come to this topic when they have read about metabolic health and notice that their standard panel only includes fasting glucose and A1c. They are trying to figure out whether there is a way to catch insulin resistance earlier. The underlying question is usually: how do I know if my metabolism is drifting before things go wrong?
What the research says
HOMA-IR is well-validated against the gold-standard euglycemic clamp study and tracks insulin sensitivity reasonably well in healthy and pre-diabetic populations (Matthews et al., 1985). The CDC estimates that about 4 in 10 US adults have prediabetes, and many do not yet show abnormal fasting glucose (CDC Insulin Resistance overview). HOMA-IR can surface that earlier window.
What to know before considering it
HOMA-IR is a screening tool, not a diagnosis. It performs less well in late-stage diabetes or in people taking insulin. Reference cutoffs vary across populations and assay methods. Any lab interpretation requires a licensed clinician who can weigh it against your full picture.
The Halftime POV
If you are paying attention to metabolic health in your 40s and 50s, HOMA-IR is one of the cheapest, earliest signals worth running once a year. It is part of the standard panel Halftime built into our clinical workflow because the cost is small and the information is real.
Related reading:
FAQ
Q: What is HOMA-IR? A: HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It is a calculation from fasting glucose and fasting insulin that estimates how resistant your cells are to insulin.
Q: How is HOMA-IR calculated? A: Multiply fasting insulin (in microunits per milliliter) by fasting glucose (in milligrams per deciliter) and divide by 405. Lower numbers suggest better insulin sensitivity.
Q: What is a normal HOMA-IR? A: Most published references treat scores under 1.5 as healthy insulin sensitivity and scores above 2.5 as suggestive of insulin resistance. Cutoffs vary across studies.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.
Sources
Sources & references
- pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/3899825/
- cdc.gov — https://www.cdc.gov/diabetes/basics/insulin-resistance.html
